Related Experiment Video
Updated: Sep 17, 2025
Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Vancomycin Resistance Streptococcus pneumoniae, a Case Report
Zana Baqi Najmadden1, Khalid Hama Salih2, Jihad Ibrahim Hama1
1University of Halabja, Halabja, Kurdistan Region, Iraq.
Insights
A rare case of vancomycin-resistant Streptococcus pneumoniae was identified in a 9-month-old infant in Iraq. This finding highlights the urgent global threat of antibiotic resistance and the need for new treatment strategies.
Area of Science:
- Infectious Diseases
- Microbiology
- Clinical Medicine
Background:
- Streptococcus pneumoniae causes invasive pneumococcal disease, particularly in children.
- Antibiotics are crucial for treating bacterial infections, but antibiotic resistance is a growing global health crisis.
- Vancomycin resistance in S. pneumoniae has not been previously reported in Iraq.
Observation:
- A 9-month-old infant presented with symptoms including fever, irritability, and decreased oral intake.
- Cerebrospinal fluid analysis revealed signs of bacterial meningitis: turbid appearance, pleocytosis, high protein, and low sugar.
- Culture and sensitivity tests identified Streptococcus pneumoniae.
Findings:
- The isolated Streptococcus pneumoniae strain exhibited resistance to vancomycin.
- This marks the first reported case of vancomycin resistance in S. pneumoniae in Iraq.
Implications:
- This case underscores the escalating challenge of antimicrobial resistance worldwide.
- The emergence of vancomycin resistance in S. pneumoniae necessitates urgent development of alternative therapeutic approaches.
- Effective strategies are crucial to combat the potential post-antibiotic era where infections become untreatable.
Abstract:
Streptococcus pneumoniae is a pathogenic bacterium that causes invasive pneumococcal disease in humans, especially pediatric patients. Antibiotics are primary therapeutic agents. Resistance to antibiotics is a growing health problem, and healthcare authorities have warned that 10 million people will die each year by 2050 and become the first killer. To date, resistance to vancomycin has not been recorded in Iraq. This study reports a 9-month-old infant presented with fever, irritability, crying, and decreased oral intake for 3 days. Cerebrospinal fluid (CSF) parameters included turbid appearance, pleocytosis, and high protein and low sugar levels. Culture and sensitivity tests revealed the growth of Streptococcus pneumoniae, which is resistant to vancomycin. Reporting vancomycin resistance in Streptococcus pneumonia adds to the growing body of research on the pandemic of drug resistance. It indicates when all antibiotics are ineffective, as in the pre-antibiotic era, and this needs a more comprehensive plan.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:53Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
Published on: October 2, 2017
Related Concept Videos
01:30Development of Antibiotic Resistance
01:28Antimicrobial Effectiveness
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia III: Complications and Assessment
01:29Pneumonia II: Pathophysiology
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...